Profenamine — CAS 522-00-9

Profenamine (Ethopropazine) is a phenothiazine derivative with anticholinergic and antihistaminic properties used in the treatment of Parkinson's disease. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It helps reduce tremor and rigidity while also offering some benefit in drug-induced extrapyramidal disorders.

• Adjunct treatment for Parkinson's disease tremor and rigidity
• Drug-induced extrapyramidal symptom management
• Combination antiparkinson therapy with levodopa
• Postencephalitic and arteriosclerotic parkinsonism

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support